Oct 9, 2014· Comment submitted by Brett Hartl, Endangered Species Policy Director on behalf of the Center for Biological Diversity (CBD)· EPA-HQ-OPP-2006-0240-0024
Filed on regulations.gov — full text not in the inline record.
EPANonrulemakingEPA-HQ-OPP-2006-0240
Clofentezine Registration Review
RIN
—
Last modified
Dec 9, 2025
Comment window
closed 4327d ago
Center for Biological Diversity filings
1
Activity
Center for Biological Diversity filed 1 comment on this docket between Oct 9, 2014 and Oct 9, 2014. 0 other organizations filed here. The comment window closed 4327d ago.
What Center for Biological Diversity filed (1)
Abstract
For further information, contact Tracy Jackson at jackson.tracy@epa.gov
View on regulations.gov →Co-filers (0)
See everyone who commented →- Center for Biological DiversityTHIS ORG1 filing · confidence 97%